Oric Pharmaceuticals Financial Overview
Oric Pharmaceuticals's market cap is currently $1.02B. The company's EPS TTM is $-0.33; its P/E ratio is ―; Oric Pharmaceuticals is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
